-
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
19 Apr 2024 20:21 GMT
… in the treatment of immune mediated diseases.
FDA approval was … development program for the drug included data from … biosimilar product referencing adalimumab (Humira).
Sales of reference … savings, while providing additional treatment options for patients.
…
-
Alvotech moves to bring its Humira biosimilar to US market
19 Apr 2024 20:14 GMT
… Food and Drug Administration (FDA) approval for Alvotech and Teva Pharmaceuticals’ Simlandi ( … formulation biosimilar to AbbVie’s Humira.
Humira is approved to treat juvenile … parent company of Pharmaceutical Technology.
Alvotech is a biotech focused solely …
-
Alvotech deal could heighten biosimilar pressure on Humira
19 Apr 2024 18:26 GMT
… version of AbbVie’s blockbuster drug Humira, Alvotech said Friday. An … treatment, Alvotech and Teva must first cut deals with drug … reported substantial declines in Humira prescriptions over the last … it directly without needing a doctor’s approval. It’s …
-
Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications are created equal
19 Apr 2024 13:31 GMT
Will Vertex’s “pipeline-in-a-product” pay off?
That’s the bet behind the company’s $4.9 billion acquisition of Alpine Immune Sciences and its mid-stage IgA nephropathy drug, which is designed to inhibit two key cytokines.
The companies …
-
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
19 Apr 2024 10:10 GMT
… biotech company specializing in the development and manufacture of biosimilar medicines … and Drug Administration (FDA) approved high-concentration interchangeable biosimilar to Humira. … partnership between Teva Pharmaceuticals and Alvotech remains …
-
Stelara biosimilar from Alvotech, Teva approved by FDA
17 Apr 2024 17:43 GMT
… ’s blockbuster psoriasis drug, Stelara.
The FDA cleared Selarsdi for treatment of moderate … number of biologic drugs.
AbbVie’s anti-inflammatory medicine Humira — sales of which … revenue from Humira dropped to $14.4 billion in 2023. Doctors may …
-
Alvotech and Teva gain FDA approval of Selarsdi for psoriasis
17 Apr 2024 12:19 GMT
… Pharmaceuticals have announced approval from the US Food and Drug Administration (FDA … a Stelara biosimilar for the treatment of plaque psoriasis and … and a Phase I trial called Study AVT04-GL- … free biosimilar to Humira, was approved by the FDA in February …
-
Crohn’s Disease With an Active Flare of Systemic Lupus Erythematosus
19 Apr 2024 20:11 GMT
… . The patient’s current medication regimen consists of Stelara 90mg … for the past week. Previous medications, including Humira, Remicade, Entyvio, mesalamine, … the failure of multiple medications, further suggestions for treatment options are needed …
-
Sandoz's Humira biosimilar nabs significant market share thanks to CVS partnership
16 Apr 2024 20:26 GMT
The nine biosimilars competing with AbbVie’s megablockbuster Humira have tried everything from exactly imitating the latest version of brand-name Humira to taking more than 80% off the list price. But where they failed before, they may …
-
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16 Apr 2024 21:55 GMT
… Johnson.
Humira® is a registered trademark of AbbVie Biotechnology Ltd. … , reported in clinical trials included the following:
… tuberculosis during and after treatment.
Malignancies
Ustekinumab products … Teva Pharmaceuticals at 1-888-483-8279 or FDA at …